Introduction
Cervical cancer is the second most common cancer in women worldwide with 5,30,000 new cases every year. A mortality of 2,70,000 cases and 5-year prevalence of 1,547,161 was reported in 2013 [1] . The highest incidence is found in developing countries out of which 25% is from India.
Epidemiological and clinical data show that the development of cervical cancer is a multifactorial process in which infection with human papillomavirus (HPV) takes a central place along with other risk factors such as smoking, immunosuppression, immunodeficiency, diet, parity, age at first fullterm pregnancy and family history [2] .
In cancer development; inflammation, angiogenesis and thrombosis are involved which strongly correlate with immune cells residing in the microenvironment of cancerous tissues. Immune cells are involved in the production of cytokines (pro-and anti-inflammatory), growth factors and adhesion molecules which promote tumor progression by a signaling cascade and provide optimal growth conditions for cancerous cells. A number of previous reports suggested that chronic inflammation is associated with precancerous intraepithelial lesion and cervical cancer [3] . IL-6 acts as a defense mechanism at acute inflammatory levels but during chronic inflammation it behaves like a pro-inflammatory cytokine involved in immune regulation [4, 5] , hematopoiesis [6, 7] and oncogenesis thereby inducing acute phase responses [8] . During chronic inflammation, IL-6 also favors mononuclear monocyte chemoattractant protein (MCP-1) secretion, angio-proliferation and antiapoptotic functions on T cells. It is expressed by a wide variety of different cell types including keratinocytes of the uterine cervix [9] . A promoter SNP-597 (A/G) in IL-6 gene located on chromosome 7p21 [10] is a susceptibility factor in many diseases like coronary heart disease, breast cancer, cervical cancer etc [11] .
Cytokine family interleukin-1 (pro-inflammatory) consists of several members including interleukin-1beta (IL-1b) and interleukin-1receptor antagonist (IL-1RN) which are components of innate immune system as well as chronic inflammation. IL-1b is a pro-inflammatory cytokine produced by blood monocytes and tissue macrophages which regulate the expression of several molecules involved in inflammation. IL-1b acts synergistically with chemical carcinogens resulting in proliferation of mutated cells and further accumulation of genetic defects. IL-1RN inhibits the activities of IL-1b by competitively binding to IL-1b receptor and modulating a variety of interleukin-1 related immune and inflammatory responses [12] [13] [14] [15] .
Tumor necrosis factor alpha (TNF-a) is another potential pro-inflammatory cytokine and plays a role in inflammation and malignant diseases [16] . TNF-a gene located on chromosome 6 between HLA class I and II regions (within the major histocompatibility complex, MHC) activates the positive cell cycle regulator NF-jB resulting in proliferation of cells, invasion and finally metastasis [17, 18] . A single nucleotide polymorphism (SNP) in the promoter region of TNF-a gene associated with its regulation and expression may contribute to the pathogenesis and promote malignant progression of cervical cancer. In the present study, the association of genetic polymorphisms in IL-6, IL-1b and TNF-a genes was studied in cervical cancer patients from north India.
Subjects and methods

Patient selection and sample collection
Our study included cervical cancer patients (n = 100) and normal control subjects (n = 100) enrolled in the outpatient unit of Department of Obstetrics and Gynecology, King George's Medical University, Lucknow, India. The study was conducted after due approval of Institutional Ethics Committee (No. 4135/R.Cell-13, dated 15/4/2013) and written consent from all subjects. The work has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments in humans. After selection, subjects were counseled and cervical biopsy was conducted by expert gynecologists and sent for histopathological examination. Clinical details of patients and other risk factors viz. smoking status, parity, abortion, and use of contraception were precisely recorded. Blood samples (2 ml) from all study subjects were collected in EDTA vials and stored at À20°C until further use. The inclusion/exclusion criteria for cases and controls are given below:
Inclusion criteria for cases:
Histopathologically proven cases of squamous cell carcinoma (SCC) all stages and cervical intraepithelial neoplasia (CIN 
DNA extraction and genotyping
Genomic DNA was extracted from peripheral blood mononuclear cells (PBMCs) using salting out method [19] with slight modifications [20] . Genotyping of three polymorphisms . The PCR products of IL-6, TNF-a and IL-1b were digested with FokI, NcoI and SacI restriction enzymes respectively (Thermo Fisher Scientific Inc., USA), electrophoresed on 12.5% polyacrylamide gels (Sisco Research Laboratories Pvt. Ltd., India), stained with EtBr (Sisco Research Laboratories Pvt. Ltd., India) and documented in Geldoc system (Vilber Lourmat, France). The genotyping results were cross checked randomly in order to confirm our methodology.
Statistical analysis
Allele frequencies and carriage rates of alleles in all groups were compared in a 2 Â 2 contingency table and genotype frequencies in a 2 Â 3 contingency table using Chi square test (v 2 ) and Fisher's exact t-test. Hardy-Weinberg equilibrium at individual locus was assessed by v 2 statistics using Statistical Package for Social Science (SPSS) version 16.0. All P values were two-sided and differences were considered statistically significant for P < 0.05. Odds Ratio (OR) at 95% confidence intervals (CI) was determined to describe the strength of association by Logistic Regression Model. The associations of cervical cancer risk factors and gene polymorphisms with cervical cancer were evaluated by Logistic Regression Model (dominant model). All statistical analyses were carried out using SPSS software, version 16.0.
Gene-gene interaction analysis
Gene-gene interaction and pairwise linkage disequilibrium (LD) based on 'D' statistics and correlation coefficient (r 2 ) of frequencies were analyzed using SHEsis [21] .
Results
A large number of women in the age group >40 years showed a higher incidence of cervical cancer as compared to the lower age group (640 year) which was evident from demographic data ( Table 1 ). Risk factors viz. higher parity, lower age at first full term pregnancy, irregular menstrual cycle, menstrual hygiene, no contraception showed significant relation with cervical cancer. A significant correlation with smoking as well as high risk human papillomavirus (HR-HPV) incidence was observed in cases (p < 0.001) ( Table 1) . Controls and cervical cancer cases (histopathologically proven) were successfully genotyped for IL-6-597A/G, IL-1b-511C/T and TNF-a-308G/A polymorphisms (Fig. 1) . The allele and genotype frequency distributions as well as carriage rates are shown in Table 2 . All allelic and genotypic frequencies were found to be in Hardy-Weinberg equilibrium (HWE). In IL-6-597A/G polymorphism, 'GG' (25%) and 'AG' (40%) genotype frequencies in cases were found to be higher in comparison to controls showing significant difference (p < 0.001) ( Table 2) . Moreover, the prevalence of -597 * G allele was significantly higher in cases (45.0%, p < 0.001) with an Odds Ratio (OR) of 5.4. The carriage rate analysis also showed that the presence of -597 * G allele of IL-6-597A/G increases the risk of cervical cancer in our population up to 6.2 times (p < 0.001) ( Table 2) . Although the frequency of cases with 'TT' genotype (57% vs 47%) and -511 * T allele (88%) was higher in comparison to controls, the IL-1b-511C/T polymorphism did not show significant association (Table 2) . TNF-a-308G/A polymorphism showed a higher 'AA' genotype frequency in cases (30%) in comparison to controls (9%) and significant difference (P < 0.001). The prevalence of -308 * A allele in cases was higher in comparison to controls (63% vs 53%) with an OR of 1.5 and showed significant association with cervical cancer (p < 0.043) ( Table 2) .
In order to examine the role of risk factors in cervical cancer, we stratified the analysis of effects of IL-6, IL-1b and TNF-a polymorphisms on cervical cancer according to various risk factors. The effect of IL-6-597A/G polymorphism on the risk of cervical cancer showing significant association included high parity (p < 0.001), lower age at full term pregnancy (p < 0.001), irregular menstrual cycle (p < 0.001), menstrual hygiene (p < 0.001) and smoking (p < 0.001) ( Table 3) . Similar result was also observed in the case of IL-1b gene polymorphism with positive HR-HPV infection status (p < 0.001) and active smoking (p < 0.001) ( Table 4 ). The association of TNFa with various risk factors such as high parity, lower age at of first full term pregnancy, irregular menstrual cycle and hygiene were found to be significant (p < 0.001) in cases of cervical carcinoma ( Table 5) .
Gene-gene interaction analysis showed that individuals with the SNP combinations G A T * and G G T * of IL-6-597A/G, TNF-a-308G/A and IL-1b-511C/T polymorphisms have an increased risk of cervical cancer up to 9.0 and 3.3 times respectively in the study population (Fig. 2) . Table 2 Genotypic, allelic and carriage rate frequencies of IL-6-597A/G, TNF-a-308G/A and IL-1b-511C/T gene polymorphisms in healthy controls (n = 100) and cervical cancer cases (n = 100). 
Discussion
Risk factors for cervical cancer showed that the development of cancer is a multifactorial process in which infection with high risk human papillomavirus (HR-HPV) takes a central place in the development of cervical cancer. However, HPV infection is not the only cause of cervical cancer but other risk cofactors have been identified including oral contraceptive use, smoking, immunosuppression, immunodeficiency, diet, parity, age at the first full-term pregnancy and family history of cervical cancer. In the present study, it was found that women of age >40 years have higher incidence of cervical cancer as compared to the age group 640 years. This might be due to the fact that during adolescence (15-19 years) cervical epithelium is more susceptible to HPV; therefore, early age (<40 years) of sexual intercourse and subsequent pregnancy become risk factors for cervical cancer [22] . It has been reported that the disease progression takes 10-15 years to manifest. Therefore, cases with HPV infection and subjected to other risk factors show the disease beyond 40 years of age [23] . It was also found that females getting pregnant at <20 years of age with more than two children are more susceptible to cervical cancer and showed significant correlation (p < 0.001). Poor menstrual hygiene such as use of homemade sanitary napkins and their reuse after washing were found to be independent risk predictors for cervical cancer in women. This factor was linked to low socio-economic conditions since the majority of the study population was illiterate and belonged to low economic strata in rural areas, and therefore showed higher frequency of cervical cancer. Functional DNA polymorphisms which alter the expression of inflammatory molecules play a decisive role at different stages of tumor development including pathogenesis, invasion and metastasis. HPV infection and inflammation during cervical cancer are critical components in progression of the disease. During HPV infection, cytokine genes responsible for inflammation are regarded as a potential source of cervical cancer risk. Inflammation involves extensive tissue remodeling events which are orchestrated by complex networks of cytokines, chemokines and bio-active lipids working across multiple cellular compartments to maintain tissue homeostasis. Only 5-10% of all cancers are caused by inheritance of mutated genes and somatic mutations, whereas the remaining 90-95% have been linked to lifestyle factors and environment [24] .
In neoplastic diseases, circulating levels of IL-6 increase markedly during development and progression of tumors. Polymorphisms in IL-6 gene are reported as susceptibility factors in several diseases such as multiple myeloma [25] , rheumatoid arthritis [4] , Castleman's disease [26] , AIDS [27, 28] , mesangial proliferative glomerulonephritis [29] , psoriasis [30] , Kaposi's sarcoma [31] , sepsis [32] , osteoporosis [33, 28] and cervical cancer [11] . The association of IL-6-597A/G polymorphism with cervical cancer in the study population showed that the prevalence of IL-6-597 * G allele was significantly Table 3 Association between cervical cancer risk factors and IL-6-597A/G gene polymorphism. higher in cases (45.0%, p < 0.0001). Gene-gene analysis also showed that promoter polymorphism in IL-6 gene in combination with -308 * A allele of TNF-a and -511 * T allele of IL-1b genetic variants increases the risk of cervical cancer up to 9.0 times in the present study (Fig. 2) . The association between IL-6 promoter polymorphism and cancer risk was evident among Asians and Africans but not Caucasians [34] .
Other IL-6 SNPs like -174G/C polymorphism has been associated with an increased risk of breast cancer [35, 36] , leukemia [37] , colorectal cancer [38] and basal cell cancer [39] .
The IL-1b polymorphism was not found to be associated with the risk of cervical cancer in the study population. There are previous reports which suggest that IL-1b may be involved in early steps of cervical carcinoma development and progression [40, 14] . Increased levels of IL-1b reduce apoptosis by changing the ratio of BCL-2/BAX protein and increased p53 mutation which leads to DNA damage in epithelial cells of the cervix [41] . Various epidemiologic risk factors of cervical cancer as positive HR-HPV infection status and active smoking are associated with IL-1b in the present study. However, it can be validated further by increasing the sample size of the study.
In our study, TNF-a polymorphism showed a significant association with various risk factors and cervical carcinomas while previous studies observed the same in Caucasian ethnic groups but not Asians [42] . In the present study -308 * A allele was higher in cases (63%) with an OR of 1.5 which was earlier shown in Portuguese population with an OR of 1.8 [43] . The women carrying TNF-a-308 * A allele were seen to have an increased disease risk up to 2 folds. In contrast, the South African population showed no association of TNF-a -308G/ A polymorphism and risk of cervical cancer [44] . The difference between these polymorphisms may be due to the variation of ethnic groups, showed sample size, patient recruitment standards and geographical or environmental factors. The present study supports a potential role of genetic variations in the TNF-a promoter region in susceptibility to cervical cancer.
The results obtained from our study are consistent with several previous studies [15, [45] [46] [47] but similar genotyping analysis in other ethnic populations are still necessary to validate the association between SNPs and susceptibility to cervical cancer. SNP studies show a considerable level of variation among various ethnic populations around the world. Therefore, it is essential to perform association studies/SNP analyses in individual populations so that they can be benefitted. Individuals at risk will be able to take prior precautionary measures and avoid or delay the onset of disease. The challenge for the future will be to understand the genotypic interactions between SNPs in the same gene or genes at different loci. Recent data implicate that cytokine gene polymorphisms are important in the pathogenesis of various neoplastic and non-neoplastic human diseases. Association between cervical cancer risk factors and TNF-a-308G/A gene polymorphism.
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